About the Study

Secondary hyperparathyroidism (SHPT): A study of the tolerance and safety of a medicine called etelcalcetide.

This study is being done for children: • 28 days to < 18 Years of age • Diagnosed with Hyperparathyroidism and Chronic Kidney Disease, receiving maintenance Hemodialysis. Secondary hyperparathyroidism (SHPT) is a condition that is characterized by too much parathyroid hormone (PTH) being produced by the parathyroid glands. "Secondary" means that the hyperparathyroidism (HPT) is caused by another condition (for example, kidney disease). Secondary HPT is associated with loss of calcium from the bones, which can lead to bone pain and fractures, and problems with blood and heart vessels. The purpose of this study is to find out more about etelcalcetide in children with SHPT.

Interested in learning more?

Full Study Name: Etelcalcetide